Skip to main content

Table 3 Day 3 positivity rates among patients enrolled at the four sites

From: Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2018

Follow-up day

Kibaha

(n = 85)(%)

Mlimba

(n = 85*)(%)

Mkuzi

(n = 88) (%)

Ujiji

(n = 88) (%)

Total

(N = 346) (%)

Day 1

63 (74.1)

70(82.3)

77(87.5)

74(84.1)

228(83.8)

Day 2

7(8.23)

5(5.9)

20(22.7)

7(7.9)

39(14.7)

Day 3

0(0)

0(0)

0(0)

0(0)

0(0)

  1. *2 patients were withdrawn from the study